Morgan Stanley’s eXoZymes Inc EXOZ Stock Holding History

Morgan Stanley’s Portfolio EXOZ Stock Details EXOZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.5K	Hold	1,250	–	–	﹤0.01%	7030
2026 Q1	$9.39K	Hold	1,250	–	–	﹤0.01%	6967
2025 Q4	$13.6K	Hold	1,250	–	–	﹤0.01%	6816
2025 Q3	$18K	Hold	1,250	–	–	﹤0.01%	6716
2025 Q2	$12.3K	Buy	+1,250	New	+$15.2K	﹤0.01%	6792

Other funds holding EXOZ

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DKCM

Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Morgan Stanley's EXOZ Position: Q2 2026 in Review

Morgan Stanley held its eXoZymes Inc (EXOZ) position steady in Q2 2026 at 1,250 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7030.

Morgan Stanley first reported a position in EXOZ in Q2 2025 and has held it in 5 quarters since. The position peaked at $18K in Q3 2025. 9 funds tracked by Wall St. Rank hold EXOZ as of Q2 2026.

Morgan Stanley held 1,250 shares of eXoZymes Inc worth $10.5K as of Q2 2026.
Morgan Stanley left its eXoZymes Inc share count unchanged in Q2 2026.
eXoZymes Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7030 holding.
Morgan Stanley first reported a position in eXoZymes Inc in Q2 2025 and has held it in 5 quarters since.
Morgan Stanley's eXoZymes Inc position peaked at $18K in Q3 2025.
9 funds tracked by Wall St. Rank held eXoZymes Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.